Search

everythinglearnresearchcommunity

for

Search:↓

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

SHBG may be a useful early indicator and treatment target for PCOS.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

A male with aromatase deficiency improved bone health with estradiol treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

New compounds may soon be tested to treat excessive hair growth in women.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

Statins may be linked to reproductive organ conditions, and their risks should be monitored.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Diazoxide applied to the skin can increase hair growth without harmful side effects.

Deslorelin may help intact male dogs regrow hair from alopecia X, with a 75% success rate and no side effects.